Host-Directed Targeting of LincRNA-MIR99AHG Suppresses Intracellular Growth of Mycobacterium tuberculosis
Macrophage polarization
DOI:
10.1089/nat.2022.0009
Publication Date:
2022-07-27T16:53:11Z
AUTHORS (15)
ABSTRACT
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) kills 1.6 million people worldwide every year, and there is an urgent need for targeting host-pathogen interactions as a strategy to reduce mycobacterial resistance current antimicrobials. Noncoding RNAs are emerging important regulators of numerous biological processes avenues exploitation in host-directed therapeutics. Although long noncoding (lncRNAs) abundantly expressed immune cells, their functional role gene regulation bacterial infections remains understudied. In this study, we identify immunoregulatory intergenic RNA, lincRNA-MIR99AHG, which upregulated mouse human macrophages upon IL-4/IL-13 stimulation downregulated after clinical Mtb HN878 strain infection peripheral blood mononuclear cells from active TB patients. To evaluate the used antisense locked nucleic acid (LNA) GapmeR-mediated oligonucleotide (ASO) lncRNA knockdown experiments. Knockdown lincRNA-MIR99AHG with ASOs significantly reduced intracellular growth pro-inflammatory cytokine production. addition, vivo treatment mice MIR99AHG burden lung spleen. Furthermore, macrophages, translocated nucleus interacts high affinity hnRNPA2/B1 following infection. Together, these findings positive regulator inflammation macrophage polarization promote possible target adjunctive therapy against TB.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (79)
CITATIONS (11)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....